Shigeki Hirabayashi
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55.
Journal: Bone marrow transplantation
Published: August 08, 2024
An atlas of transcribed enhancers across helper T cell diversity for decoding human diseases.
Journal: Science (New York, N.Y.)
Published: July 04, 2024
Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells.
Journal: Blood neoplasia
Published: February 02, 2024
HLA-matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML.
Journal: EJHaem
Published: January 03, 2024
Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ ALL: A retrospective nationwide study.
Journal: American journal of hematology
Published: March 27, 2023
HTLV-1 bZIP factor impairs DNA mismatch repair system.
Journal: Biochemical and biophysical research communications
Published: February 28, 2023
Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients.
Journal: Cytotherapy
Published: February 09, 2022
Effect of Multiple HLA Locus Mismatches on Outcomes after Single Cord Blood Transplantation.
Journal: Transplantation and cellular therapy
Published: January 27, 2022
Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy-refractory or relapsed disease prior to allogeneic stem cell transplantation.
Journal: British journal of haematology
Published: May 01, 2021
Last Updated: 09/26/2026